Features of Menstrual Disorders in Obese Women and Ways for Their Correction Using Orlistat

Main Article Content

O.S. Payenok
M.O. Kostiv


The research deals with the problem of reproductive health in women with obesity. In obese women, oligomenorrhea (in 62.2 % of examines patients) prevails in the structure of menstrual disorders. On the background of obesity, incidence of metabolic syndrome is 68.9 %, and impaired glucose tolerance — 35.6 %. Administration of Xenical® for six months enables to obtain menstrual function recovery in 75.6 % of women with obesity, and in 31.1 % — recovery of ovarian function.

Article Details

How to Cite
Payenok, O., and M. Kostiv. “Features of Menstrual Disorders in Obese Women and Ways for Their Correction Using Orlistat”. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine), no. 5.61, Sept. 2014, pp. 107-10, doi:10.22141/2224-0721.5.61.2014.76862.
To Endocrinologist from Other Expert


Кузнецова И.В., Михаэлянц В.М., Санта-Мария-Фернандес Д.О., Гитель Е.П. Нарушения менструального цикла у подростков и молодых женщин с ожирением // Ожирение и метаболизм. — 2010. — № 4. — С. 29-34.

Паєнок О.С. Гормони жирової тканини і гестаційний цукровий діабет / О.С. Паєнок, О.О. Коритко, Р.І. Петруняк // Міжнародний ендокринологічний журнал. — 2013. — № 7. — С. 60-66.

Chanoine J.-P., Hampl S., Jensen C. et al. Effect of Orlistat on weight and body composition in obese adolescents: a randomized controlled trial // JAMA. — 2005. — Vol. 293(23). — P. 2873-2883.

Gokler M.E., Unsal A., Arslantas D. The prevalence of infertility and loneliness among women aged 18-49 years who are living in semi-rural areas in Western Turkey // Int. J. Fertil. Steril. — 2014. — Vol. 8(2). — P. 155-162.

Guelinckx I. et al. Maternal obesity: pregnancy complications, gestational weight gain and nutrition // Obesity Reviews. — 2008. — Vol. 9. — P. 140-150.

Jayagopal V., Kilpatrick E.S., Holding S. et al. Orlistat is as beneficial as metformin in the treatment of polycystic ovarian syndrome // J. Clin. Endocrinol. Metab. — 2005. — Vol. 90(2). — P. 729-733.

Pasquali R., Gambineri A. Metabolic effects of obesity on reproduction // Reprod. Biomed. Online. — 2006. — Vol. 12(5). — P. 542-551.

Sari R., Balci M.K., Coban E., Yazicioglu G. Comparition of effect of orlistat vs orlistat plus metformin on weight loss and insulin resistance in obese women // Int. J. Obes. — 2004. — Vol. 28(8). — P. 1059-1063.

Stepan H., Scheithauer S., Dornhofer N. et al. Obesity as an obstetric risk factor: does it matter in a perinatal center? // Obesity. — 2006. — Vol. 14. — P. 770-773.